Search research articles
Contact Us
Filters
Showing results (71-80 of 151) with videos related to
Page
of 16
Sort By:
Oncotarget
|
November 9, 2016
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function
Anders E Berglund, Kristen E N Scott, Weimin Li, et al.
Blood Cancer Discovery
|
April 18, 2023
The Polyamine-Hypusine Circuit Controls an Oncogenic Translational Program Essential for Malignant Conversion in MYC-Driven Lymphoma
Shima Nakanishi, Jiannong Li, Anders E Berglund, et al.
Molecular and Cellular Biology
|
March 4, 2005
The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis
Monica Cardone, Ayten Kandilci, Cintia Carella, et al.
Cancer Research
|
October 2, 2015
Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis
Franz X Schaub, Md Shamim Reza, Colin A Flaveny, et al.
Molecular and Cellular Biology
|
October 13, 2006
Essential role of phospholipase C gamma 2 in early B-cell development and Myc-mediated lymphomagenesis
Renren Wen, Yuhong Chen, Li Bai, et al.
Molecular and Cellular Biology
|
November 9, 2016
Functional Roles of Acetylated Histone Marks at Mouse Meiotic Recombination Hot Spots
Irina V Getun, Zhen Wu, Mohammad Fallahi, et al.
Nature
|
August 12, 2005
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
Michael T Hemann, Anka Bric, Julie Teruya-Feldstein, et al.
Molecular Cancer Research : MCR
|
March 4, 2010
Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis
Jennifer B Old, Susanne Kratzat, Alexander Hoellein, et al.
Genes & Development
|
October 9, 2002
c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression
Troy A Baudino, Catriona McKay, Helene Pendeville-Samain, et al.
Blood
|
March 17, 2007
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance
Jennifer S Carew, Steffan T Nawrocki, Charissa N Kahue, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 151) with videos related to
Sort By:
Page
of 16
Oncotarget
|
November 9, 2016
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function
Anders E Berglund, Kristen E N Scott, Weimin Li, et al.
Blood Cancer Discovery
|
April 18, 2023
The Polyamine-Hypusine Circuit Controls an Oncogenic Translational Program Essential for Malignant Conversion in MYC-Driven Lymphoma
Shima Nakanishi, Jiannong Li, Anders E Berglund, et al.
Molecular and Cellular Biology
|
March 4, 2005
The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis
Monica Cardone, Ayten Kandilci, Cintia Carella, et al.
Cancer Research
|
October 2, 2015
Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis
Franz X Schaub, Md Shamim Reza, Colin A Flaveny, et al.
Molecular and Cellular Biology
|
October 13, 2006
Essential role of phospholipase C gamma 2 in early B-cell development and Myc-mediated lymphomagenesis
Renren Wen, Yuhong Chen, Li Bai, et al.
Molecular and Cellular Biology
|
November 9, 2016
Functional Roles of Acetylated Histone Marks at Mouse Meiotic Recombination Hot Spots
Irina V Getun, Zhen Wu, Mohammad Fallahi, et al.
Nature
|
August 12, 2005
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
Michael T Hemann, Anka Bric, Julie Teruya-Feldstein, et al.
Molecular Cancer Research : MCR
|
March 4, 2010
Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis
Jennifer B Old, Susanne Kratzat, Alexander Hoellein, et al.
Genes & Development
|
October 9, 2002
c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression
Troy A Baudino, Catriona McKay, Helene Pendeville-Samain, et al.
Blood
|
March 17, 2007
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance
Jennifer S Carew, Steffan T Nawrocki, Charissa N Kahue, et al.
Page
of 16